{"id":"aspirin-loading-dose","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Gastrointestinal bleeding"},{"rate":"5-10","effect":"Dyspepsia"},{"rate":"2-5","effect":"Nausea"},{"rate":"<1","effect":"Hemorrhagic stroke"},{"rate":"<1","effect":"Allergic reaction / Anaphylaxis"}]},"_chembl":{"chemblId":"CHEMBL25","moleculeType":"Small molecule","molecularWeight":"180.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin acetylates serine residues on COX-1 and COX-2 enzymes, permanently blocking their catalytic activity. This prevents the synthesis of thromboxane A2 in platelets, a potent platelet activator and vasoconstrictor, thereby reducing platelet aggregation and thrombotic events. A loading dose delivers a rapid, high concentration to achieve quick antiplatelet effects, particularly important in acute coronary syndromes.","oneSentence":"Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes to reduce thromboxane A2 production and platelet aggregation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:44.368Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome (ACS) and myocardial infarction"},{"name":"Stroke prevention in patients with prior ischemic stroke or transient ischemic attack"},{"name":"Stable coronary artery disease"},{"name":"Primary prevention of cardiovascular events (select populations)"}]},"trialDetails":[{"nctId":"NCT06650488","phase":"PHASE4","title":"Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia","status":"RECRUITING","sponsor":"Todd C. Lee MD MPH FIDSA","startDate":"2026-01-15","conditions":"Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bloodstream Infection","enrollment":300},{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT06037889","phase":"PHASE3","title":"Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2023-11-09","conditions":"Branch Atheromatous Disease","enrollment":516},{"nctId":"NCT04809818","phase":"PHASE1","title":"A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects","status":"COMPLETED","sponsor":"Lumosa Therapeutics Co., Ltd.","startDate":"2021-03-21","conditions":"Acute Ischemic Stroke","enrollment":65},{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT04014803","phase":"PHASE4","title":"Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2020-01-13","conditions":"Coronary Artery Disease","enrollment":3500},{"nctId":"NCT06228456","phase":"PHASE4","title":"Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-04-01","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT04184921","phase":"PHASE2","title":"Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients","status":"COMPLETED","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2019-01-01","conditions":"Lung Cancer Non-small Cell Stage IV","enrollment":216},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT06853535","phase":"PHASE3","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-05-23","conditions":"Acute Ischemic Stroke, Clopidogrel Resistance","enrollment":5138},{"nctId":"NCT07275749","phase":"PHASE3","title":"Acetyl-leucine in Post-stroke Ataxia","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2025-12-01","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT06591377","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-08-10","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT03869268","phase":"PHASE4","title":"The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2019-04-24","conditions":"Acute Coronary Syndrome","enrollment":72},{"nctId":"NCT06638151","phase":"PHASE2","title":"Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-09-02","conditions":"Acute Ischemic Stroke","enrollment":200},{"nctId":"NCT06591338","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-09-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT07095790","phase":"PHASE4","title":"Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2025-08-30","conditions":"Mild Stroke","enrollment":580},{"nctId":"NCT03465644","phase":"PHASE4","title":"TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI","status":"COMPLETED","sponsor":"Duk-Woo Park, MD","startDate":"2019-02-12","conditions":"Coronary Stenoses","enrollment":2018},{"nctId":"NCT06943586","phase":"NA","title":"Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-04-09","conditions":"Stroke, Transient Ischemic Attack (TIA)","enrollment":200},{"nctId":"NCT05329155","phase":"NA","title":"Early Administration of Heparin At FMC for PPCI of STEMI Patients","status":"COMPLETED","sponsor":"Renmin Hospital of Wuhan University","startDate":"2022-07-20","conditions":"STEMI, Primary PCI","enrollment":1145},{"nctId":"NCT06601127","phase":"PHASE2","title":"Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).","status":"RECRUITING","sponsor":"Tianjin Institute of Pharmaceutical Research Co., Ltd","startDate":"2025-02-21","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT03543683","phase":"PHASE2","title":"Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC","status":"COMPLETED","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2018-01-01","conditions":"Non-Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, EGFR T790M","enrollment":115},{"nctId":"NCT04410328","phase":"PHASE3","title":"Aggrenox To Treat Acute Covid-19","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-10-21","conditions":"Covid19","enrollment":98},{"nctId":"NCT04936191","phase":"NA","title":"Dynamic Change of Coronary Artery Curvature","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2022-11-18","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT03606642","phase":"PHASE2","title":"SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy","status":"TERMINATED","sponsor":"HonorHealth Research Institute","startDate":"2018-11-19","conditions":"Coronary Artery Disease, Atherosclerosis, Stent Placement","enrollment":50},{"nctId":"NCT05926271","phase":"PHASE2","title":"POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy","status":"RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2023-07-15","conditions":"Acute Coronary Syndrome, CYP2C19 Polymorphism","enrollment":200},{"nctId":"NCT06587347","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-20","conditions":"Acute Stroke, Ischemic Stroke, Acute, Cerebral Infarction","enrollment":302},{"nctId":"NCT02777580","phase":"PHASE4","title":"STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2017-08-01","conditions":"Myocardial Infarction","enrollment":609},{"nctId":"NCT06591390","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-02-09","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06591299","phase":"PHASE3","title":"Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-04-15","conditions":"Ischemic Stroke","enrollment":870},{"nctId":"NCT06591351","phase":"PHASE3","title":"Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Ischemic Stroke","enrollment":870},{"nctId":"NCT06591312","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT05117866","phase":"NA","title":"Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Meditrix Corp","startDate":"2020-09-15","conditions":"Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":307},{"nctId":"NCT06196047","phase":"PHASE3","title":"Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2023-12-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT00089895","phase":"PHASE3","title":"EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11-01","conditions":"Myocardial Ischemia, Acute Coronary Syndrome","enrollment":9406},{"nctId":"NCT04122170","phase":"PHASE2","title":"Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old","status":"COMPLETED","sponsor":"SFJ Pharmaceuticals, Inc.","startDate":"2019-09-24","conditions":"Healthy","enrollment":207},{"nctId":"NCT06015477","phase":"NA","title":"Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-01-01","conditions":"Intracranial Aneurysm, Stent Complication","enrollment":180},{"nctId":"NCT06254391","phase":"PHASE2","title":"Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2023-07-03","conditions":"Myocardial Infarction, Acute Coronary Syndrome","enrollment":40},{"nctId":"NCT05209412","phase":"NA","title":"Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2022-02-01","conditions":"De Novo Stenosis, Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":370},{"nctId":"NCT05700266","phase":"PHASE2, PHASE3","title":"Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-12-30","conditions":"Ischemic Stroke, Intracranial Atherosclerosis, Stenosis","enrollment":1180},{"nctId":"NCT04057300","phase":"PHASE4","title":"Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2018-10-01","conditions":"Acute Coronary Syndrome","enrollment":1038},{"nctId":"NCT05978791","phase":"","title":"Study on the Thrombolytic Effect of Platelet Membrane Coated Recombinant Staphylokinase on Human Arterial Thrombus","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-10-11","conditions":"Arterial Thrombosis","enrollment":24},{"nctId":"NCT05974033","phase":"NA","title":"IntraCranial Angiography-derived Fraction Flow-guided Percutaneous Transluminal Angioplasty and Stenting Versus Medical Therapy (ICAS-MT)","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2023-08","conditions":"ICAS - Intracranial Atherosclerosis","enrollment":536},{"nctId":"NCT05902000","phase":"NA","title":"Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion","status":"UNKNOWN","sponsor":"Xueli Cai","startDate":"2023-06-14","conditions":"Thrombectomy, Tandem Occlusion, Stroke","enrollment":222},{"nctId":"NCT03188705","phase":"PHASE4","title":"CES1 Carriers in the PAPI Study","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2019-10-14","conditions":"Heart Diseases, Coronary Disease, Coronary Artery Disease","enrollment":6},{"nctId":"NCT04944615","phase":"NA","title":"To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.","status":"RECRUITING","sponsor":"CCRF Inc., Beijing, China","startDate":"2022-10-21","conditions":"Chronic Total Occlusion of Coronary Artery","enrollment":1448},{"nctId":"NCT04766437","phase":"PHASE2","title":"Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-02-19","conditions":"Non ST Segment Elevation Acute Coronary Syndrome","enrollment":75},{"nctId":"NCT02869009","phase":"PHASE3","title":"Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2016-11","conditions":"Ischemic Stroke","enrollment":3000},{"nctId":"NCT05554822","phase":"PHASE3","title":"Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study","status":"UNKNOWN","sponsor":"Azienda Ospedaliero Universitaria Maggiore della Carita","startDate":"2021-06-14","conditions":"Left Atrial Appendage Occlusion, Antiplatelet Therapy","enrollment":574},{"nctId":"NCT00664040","phase":"NA","title":"Heredity and Phenotype Intervention (HAPI) Heart Study","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2003-05","conditions":"Cardiovascular Diseases","enrollment":868},{"nctId":"NCT04491695","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Capital Medical University","startDate":"2020-09-12","conditions":"Acute Stroke","enrollment":420},{"nctId":"NCT02677545","phase":"PHASE2","title":"Ticagrelor Versus Clopidogrel in Carotid Artery Stenting","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2016-12","conditions":"Carotid Artery Stenosis","enrollment":210},{"nctId":"NCT05240781","phase":"NA","title":"Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk","status":"UNKNOWN","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2021-09-29","conditions":"High Bleeding Risk, Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":280},{"nctId":"NCT04331145","phase":"PHASE4","title":"Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation","status":"COMPLETED","sponsor":"Andres Iñiguez Romo","startDate":"2020-06-23","conditions":"Symptomatic Aortic Stenosis","enrollment":40},{"nctId":"NCT03701360","phase":"","title":"Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2018-10-30","conditions":"Stroke","enrollment":1199},{"nctId":"NCT04078737","phase":"PHASE3","title":"Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2019-09-23","conditions":"Stroke, Transient Ischemic Attack","enrollment":6412},{"nctId":"NCT04695106","phase":"PHASE4","title":"Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2021-10-25","conditions":"Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome","enrollment":2230},{"nctId":"NCT05045274","phase":"NA","title":"The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-12","conditions":"STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction","enrollment":300},{"nctId":"NCT03884530","phase":"PHASE3","title":"Ticagrelol Versus Aspirin in Ischemic Stroke","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2019-05-01","conditions":"Acute Stroke, Ischemic Stroke","enrollment":169},{"nctId":"NCT04808895","phase":"PHASE3","title":"Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-04-01","conditions":"COVID-19, Thrombosis Pulmonary","enrollment":204},{"nctId":"NCT02989558","phase":"PHASE3","title":"A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI","status":"COMPLETED","sponsor":"University of Athens","startDate":"2016-12","conditions":"Aortic Valve Stenosis","enrollment":90},{"nctId":"NCT03533153","phase":"PHASE1, PHASE2","title":"Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2021-03-01","conditions":"Myocardial Infarction","enrollment":90},{"nctId":"NCT04754789","phase":"PHASE3","title":"Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-02-20","conditions":"ST Elevation Myocardial Infarction","enrollment":160},{"nctId":"NCT02618837","phase":"PHASE4","title":"Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2015-12-14","conditions":"Unstable Angina or Non ST Elevated Myocardial Infarction","enrollment":2520},{"nctId":"NCT04492501","phase":"NA","title":"Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan","status":"COMPLETED","sponsor":"UNICEF","startDate":"2020-04-01","conditions":"Covid19, Cytokine Release Syndrome, Critical Illness","enrollment":600},{"nctId":"NCT02506140","phase":"PHASE2, PHASE3","title":"Platelet Reactivity in Acute Non-disabling Cerebrovascular Events","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2015-08","conditions":"Stroke, Ischemic Attack, Transient","enrollment":675},{"nctId":"NCT03532698","phase":"","title":"Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)","status":"UNKNOWN","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2020-08-01","conditions":"Non-Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, EGFR T790M","enrollment":100},{"nctId":"NCT03552354","phase":"PHASE4","title":"Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2017-10-25","conditions":"Stroke, Ischemic","enrollment":120},{"nctId":"NCT02531165","phase":"NA","title":"Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2015-09","conditions":"Acute Myocardial Infarction","enrollment":38},{"nctId":"NCT00979589","phase":"PHASE3","title":"Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2009-12","conditions":"Stroke, Transient Ischemic Attack","enrollment":5100},{"nctId":"NCT02247128","phase":"PHASE4","title":"Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2014-01","conditions":"Aortic Valve Disease, Myocardial Infarction, Stroke","enrollment":1016},{"nctId":"NCT04368377","phase":"PHASE2","title":"Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19","status":"COMPLETED","sponsor":"University of Milan","startDate":"2020-04-06","conditions":"Pneumonia, Viral, Corona Virus Infection, Respiratory Failure","enrollment":5},{"nctId":"NCT03039205","phase":"PHASE2","title":"Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-11-07","conditions":"Platelet Aggregation, Adenosine, Coronary Artery Disease","enrollment":90},{"nctId":"NCT04330872","phase":"PHASE4","title":"An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.","status":"COMPLETED","sponsor":"Hamad Medical Corporation","startDate":"2019-08-26","conditions":"Stroke, Ischemic","enrollment":42},{"nctId":"NCT03454841","phase":"","title":"Daily Variability of Platelet Aggregation in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor","status":"COMPLETED","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2018-02-26","conditions":"Acute Myocardial Infarction","enrollment":73},{"nctId":"NCT02260622","phase":"PHASE2","title":"Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2014-10","conditions":"Critical Limb Ischemia","enrollment":20},{"nctId":"NCT04121611","phase":"NA","title":"Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2019-10-14","conditions":"Stroke of Basilar Artery, Optical Coherence Tomography, Antithrombotics","enrollment":25},{"nctId":"NCT01597375","phase":"PHASE2","title":"Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)","status":"COMPLETED","sponsor":"Elliot Israel, MD","startDate":"2012-08-31","conditions":"Asthma, Aspirin-Induced, Aspirin Exacerbated Asthma","enrollment":46},{"nctId":"NCT02285751","phase":"PHASE2","title":"High \"on Treatment\" Platelet Reactivity in the Intensive Care Unit","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2012-11","conditions":"Critical Illness","enrollment":200},{"nctId":"NCT02922673","phase":"NA","title":"The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2016-09","conditions":"Endotoxemia","enrollment":30},{"nctId":"NCT01510327","phase":"PHASE3","title":"PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2009-10","conditions":"Coronary Artery Disease","enrollment":22},{"nctId":"NCT01802775","phase":"PHASE2","title":"Edoxaban in Peripheral Arterial Disease","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2013-02-06","conditions":"Peripheral Arterial Disease","enrollment":203},{"nctId":"NCT02295826","phase":"PHASE2","title":"Dabigatran Following Transient Ischemic Attack and Minor Stroke","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2015-01","conditions":"Transient Ischemic Attack, Minor Ischemic Stroke","enrollment":300},{"nctId":"NCT00991029","phase":"PHASE3","title":"Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2010-05-28","conditions":"Ischemic Attack, Transient","enrollment":4881},{"nctId":"NCT01589978","phase":"PHASE4","title":"PROMUS Element Plus US Post-Approval Study","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2012-05","conditions":"Coronary Artery Disease","enrollment":2681},{"nctId":"NCT01661322","phase":"PHASE3","title":"Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke","status":"TERMINATED","sponsor":"University of Nottingham","startDate":"2009-04","conditions":"Stroke","enrollment":3096},{"nctId":"NCT02519608","phase":"PHASE2","title":"ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts","status":"COMPLETED","sponsor":"University Hospital of Ferrara","startDate":"2015-09","conditions":"Coronary Artery Disease, Chronic Obstructive Pulmonary Disease","enrollment":44},{"nctId":"NCT01823510","phase":"PHASE4","title":"Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Juan J Badimon","startDate":"2013-07","conditions":"Type-2 Diabetes Mellitus, Coronary Artery Disease","enrollment":20},{"nctId":"NCT02201394","phase":"PHASE4","title":"Reversing Ticagrelor's Effects With Fresh Platelets","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-07","conditions":"Coronary Artery Disease","enrollment":20},{"nctId":"NCT01994720","phase":"PHASE3","title":"[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-01-07","conditions":"Acute Ischaemic Stroke, Transient Ischaemic Attack","enrollment":13307},{"nctId":"NCT00684203","phase":"PHASE2","title":"Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-12-01","conditions":"Atherosclerosis, Myocardial Ischemia, Myocardial Infarction","enrollment":120},{"nctId":"NCT01968122","phase":"","title":"Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China","status":"COMPLETED","sponsor":"Zhongrong Miao","startDate":"2013-09","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT03005704","phase":"NA","title":"Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2017-01","conditions":"Ticagrelor, Aspirin, Platelet Dysfunction Due to Drugs","enrollment":10},{"nctId":"NCT00263211","phase":"PHASE2","title":"A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2006-01","conditions":"Breast Neoplasms","enrollment":48},{"nctId":"NCT03078257","phase":"PHASE1","title":"Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2016-01-01","conditions":"Coronary Artery Disease","enrollment":90},{"nctId":"NCT01504867","phase":"PHASE2","title":"LIPS-A: Lung Injury Prevention Study With Aspirin","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":400},{"nctId":"NCT02042534","phase":"PHASE2","title":"Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2014-01","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":195},{"nctId":"NCT02384070","phase":"NA","title":"Simplified Anti-Thrombotic Therapy for FFR","status":"COMPLETED","sponsor":"Odessa Heart Institute","startDate":"2009-01","conditions":"Coronary Artery Disease","enrollment":300},{"nctId":"NCT03001960","phase":"PHASE3","title":"Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2017-03","conditions":"Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Intracranial Embolism","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Acetylsalicylic acid","ASA"],"phase":"marketed","status":"active","brandName":"Aspirin loading dose","genericName":"Aspirin loading dose","companyName":"Icahn School of Medicine at Mount Sinai","companyId":"icahn-school-of-medicine-at-mount-sinai","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes to reduce thromboxane A2 production and platelet aggregation. Used for Acute coronary syndrome (ACS) and myocardial infarction, Stroke prevention in patients with prior ischemic stroke or transient ischemic attack, Stable coronary artery disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}